FDA Accepts Tzield for Expedited Review Under The Commissioner’s National Priority Voucher Program | PharmExec
FDA Accepts Tzield for Expedited Review Sanofi's Tzield has gained FDA's expedited review, promising rapid access to innovative treatment for type 1 diabetes and addressing significant med…